Production (Stage)
Proto Script Pharmaceutical Corp.
PSCR
$0.0003
$0.000.00%
OTC PK
| 09/30/2017 | 06/30/2017 | 03/31/2017 | 12/31/2016 | 09/30/2016 | |
|---|---|---|---|---|---|
| Net Income | -283.70K | -332.60K | -505.90K | -7.26M | 100.00 |
| Total Depreciation and Amortization | 2.60K | 2.20K | 2.00K | 1.50K | 1.20K |
| Total Amortization of Deferred Charges | 110.00K | 108.80K | 69.10K | -- | -- |
| Total Other Non-Cash Items | 95.80K | -30.60K | 161.90K | 6.87M | -- |
| Change in Net Operating Assets | 51.00K | 147.50K | 57.80K | 438.60K | -39.60K |
| Cash from Operations | -24.30K | -104.70K | -215.00K | 40.90K | -38.20K |
| Capital Expenditure | -600.00 | -11.60K | -9.40K | -12.20K | -3.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -600.00 | -11.60K | -9.40K | -12.20K | -3.00K |
| Total Debt Issued | 24.90K | 8.70K | 328.50K | -30.90K | 30.50K |
| Total Debt Repaid | -- | 51.30K | -51.30K | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 0.00 | 0.00 |
| Cash from Financing | 24.90K | 60.00K | 277.20K | -30.90K | 30.50K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.00 | -56.40K | 52.90K | -2.30K | -10.70K |